Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCR-ABL Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT02903277
What this trial is testing

National Observatory of Chronic Myeloid Leukemia Adolescent and Young Adults Treated With Tyrosine Kinase Inhibitors in First Intent

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Centre Hospitalier Universitaire de Nice
Testing effectiveness (Phase 2)UnknownNCT02422719
What this trial is testing

Radotinib as 3rd or Later Line Therapy in CP-CML

Who this might be right for
Chronic Myeloid Leukemia
Ulsan University Hospital 73
Not applicableStudy completedNCT00947830
What this trial is testing

Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Brian Leber 81
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT01279473
What this trial is testing

Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT01698905
What this trial is testing

Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 163
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04060277
What this trial is testing

Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more
City of Hope Medical Center 7
Testing effectiveness (Phase 2)Study completedNCT01310010
What this trial is testing

Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 30
Testing effectiveness (Phase 2)Ended earlyNCT00392782
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 24
Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Post-approval studies (Phase 4)Study completedNCT01578213
What this trial is testing

Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients

Who this might be right for
Chronic Myeloid Leukemia
University of Milano Bicocca 112
Testing effectiveness (Phase 2)Study completedNCT00381550
What this trial is testing

3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeBlastic Phase Chronic Myelogenous Leukemia+7 more
National Cancer Institute (NCI) 35
Not applicableStudy completedNCT00988013
What this trial is testing

Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaLymphoblastic LeukemiaAcute Leukemia+2 more
University of Illinois at Chicago 14
Not applicableUnknownNCT01752062
What this trial is testing

Observational Study of Conception/Pregnancy in Adult Patients With CML Treated With Tyrosine Kinase Inhibitors

Who this might be right for
Chronic Myeloid LeukemiaPregnancy
Gruppo Italiano Malattie EMatologiche dell'Adulto 148
Large-scale testing (Phase 3)Study completedNCT04948333
What this trial is testing

Asciminib Treatment Optimization in ≥ 3rd Line CML-CP

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 199
Not applicableStudy completedNCT00919425
What this trial is testing

S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 1,294
Early research (Phase 1)Study completedNCT00077467
What this trial is testing

Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00004009
What this trial is testing

R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
University of Maryland, Baltimore
Next Page